Last Price
13.00
Today's Change
-0.915 (6.57%)
Day's Change
12.75 - 13.76
Trading Volume
131,897
Exchange: NASDAQ Global Select NASDAQ Global Select
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Sandeep C. Kulkarni M.D. Dr. Sandeep C. Kulkarni M.D.
Full Time Employees: 74 74
IPO Date: 2021-05-07 2021-05-07
CIK: 0001827506 0001827506
ISIN: US89157D1054 US89157D1054
CUSIP: 89157D105 89157D105
Beta: 0.00 0.00
Last Dividend: 0.00 0.00
Dcf Diff: -15.64 -15.64
Dcf: 29.56 29.56
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.